Effects of Subcutaneously Infiltrated Nicardipine on the Success Rate of Radial Artety Cannulation

NCT ID: NCT05920538

Last Updated: 2023-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

190 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-13

Study Completion Date

2024-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to compare the success rate of subcutaneously infiltrated nicardipine to normal saline in radial artery cannulation

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Radial Artery Cannulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nicardipine

Using nicardipine 0.5 mg(0.5ml) subcutaneously infiltrated by ultrasound before redial artery cannulation.

Group Type EXPERIMENTAL

Nicardipine

Intervention Type DRUG

Subcutaneous infiltrate drug at puncture site by ultrasound-guided

Normal saline

Using normal saline 0.5ml subcutaneously infiltrated by ultrasound before redial artery cannulation

Group Type PLACEBO_COMPARATOR

Normal saline

Intervention Type OTHER

Subcutaneous infiltrate NSS at puncture site by ultrasound-guided

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nicardipine

Subcutaneous infiltrate drug at puncture site by ultrasound-guided

Intervention Type DRUG

Normal saline

Subcutaneous infiltrate NSS at puncture site by ultrasound-guided

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18-75 years
* the patient who need to arterial line

Exclusion Criteria

* allergy to nicardipine
* history of peripheral artery disease
* BMI \> 40 kg/m2
* unwilling to participate or denial of informed consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mahidol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Phuriphon Songarj, MD

Role: STUDY_DIRECTOR

Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Anesthesiology Department

Bangkok, , Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

764/2565(IRB3)

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.